Related Experiment Videos
Heart failure in children -- mechanical assistance
M Deiwick1, A Hoffmeier, T D T Tjan
1Department of Thoracic and Cardiovascular Surgery, University Hospital Münster, Münster, Germany. michael.deiwick@ukmuenster.de
The Thoracic and Cardiovascular Surgeon
|February 11, 2005
Summary
Mechanical circulatory support devices are crucial for pediatric heart failure, but options lag behind adult technology. Newer pulsatile devices show promise for children, especially with organ shortages, offering better outcomes than current mainstays.
Area of Science:
- Pediatric Cardiology
- Cardiovascular Surgery
- Biomedical Engineering
Background:
- Mechanical circulatory support (MCS) is vital for pediatric heart failure treatment.
- Pediatric MCS technology development trails behind adult innovations.
- Organ donor scarcity exacerbates challenges in pediatric heart transplantation.
Purpose of the Study:
- To review the current state and advancements in pediatric mechanical circulatory support.
- To compare the efficacy of emerging pulsatile devices with existing support systems.
- To highlight the critical considerations for selecting appropriate MCS in pediatric patients.
Main Methods:
- Review of current literature on pediatric mechanical circulatory support.
- Analysis of outcomes data for various MCS devices in children.
- Comparison of pulsatile paracorporeal ventricular assist devices with extracorporeal membrane oxygenation and centrifugal pumps.
Main Results:
- Newly developed pulsatile paracorporeal ventricular assist devices show excellent results in children.
- These advanced devices outperform extracorporeal membrane oxygenation and centrifugal pumps for long-term support.
- Careful consideration of patient physiology, including respiratory failure, is crucial for optimal outcomes, especially in smaller patients.
Conclusions:
- Pulsatile paracorporeal ventricular assist devices represent a significant advancement in pediatric MCS.
- These devices offer superior options compared to current mainstays for pediatric heart failure.
- Tailoring MCS selection to individual pediatric patient needs is paramount for successful treatment.